For some patients, there are no (or no longer) established treatment options, or specific genetic alterations in the tumor DNA have been identified. For this group of patients, the Center for Personalized Medicine (ZPM), which is currently being established at the UKA, offers a weekly Molecular Tumor Board (MTB): This is an inter-organ, interdisciplinary conference that focuses on the above-mentioned molecular changes in the genetic material of tumor cells.
For each individual case discussed in the MTB, advanced molecular diagnostics are performed in advance. The individual molecular analyses of each cancer patient are then discussed together with the clinical findings in the MTB.
If appropriate, we can offer patients with advanced or rare cancers a personalized treatment option. If possible, this should be done in the context of a clinical trial.
The goal of personalized cancer therapy is to identify the most effective treatment options while avoiding less effective and more invasive therapies.
Are you a referring physician?
We kindly invite you to refer patients who meet the above inclusion criteria to the ZPM's MTB.
You are also welcome to attend the MTB yourself to present the patients in your care. This is possible both, in person and via videoconference provided by the ZPM.
The registration form for the MTB can be found here:
Are you a cancer patient?
Your physician can refer you to the ZPM's MTB if you meet the above inclusion criteria.
Cancer, especially in an advanced stage, is a very stressful experience - for you and your relatives. In order to provide you with comprehensive information, we have compiled an information sheet for you with the most frequently asked questions and answers about the MTB:
>> Flyer <<
The MTB Office is the first point of contact for patients and referring physicians.
Monday through Friday from 8:00 a.m. to 12:00 p.m.
